Targeting metabolic dysfunction to improve survival during cancer (#60)
5:30 PM
Structural and Functional Characterization of Muscle-Specific AMPK—A Therapeutic Target for Type 2 Diabetes Mellitus (#61)
6:50 PM
An in vivo functional survey of substrates of AMPK-related kinases in non-small cell lung cancer (#62)
8:10 PM
Extracellular vesicles are enriched in activated AMPK following acute exercise. (#63)
9:30 PM
Novel torin1-sensitive phosphorylation sites on AMPK uncover regulation of cell proliferation under nutrient stress (#64)
10:50 PM
Sex specific response to cardiomyocyte-specific, inducible AMPK α1/α2 deletion (#65)
12:10 AM
Hierarchical inhibition of mTORC1 by glucose starvation-triggered AXIN lysosomal translocation and by AMPK (#66)
1:30 AM
Caspase-mediated nuclear retention of the AMPK-α1 energy sensor during apoptosis (#67)
2:50 AM
The designer cytokine and AMPK activator IC7Fc improves hepatosteatosis in the pathogenesis of non-alcoholic steatohepatitis (#78)
3:10 AM